What question did this study set out to answer?

April 8, 2008

Comparison of the Results of the Treatment of Adolescents and Young Adults With Standard-Risk Acute Lymphoblastic Leukemia With the Programa Español de Tratamiento en Hematología Pediatric-Based Protocol ALL-96

Key Points

To compare treatment outcomes of adolescents and young adults with standard-risk acute lymphoblastic leukemia using the pediatric ALL-96 protocol.
Comparison of treatment responses in adolescents and young adults with SR ALL using the ALL-96 protocol.
Assessment of hematologic toxicity levels between both age groups.
Analysis of age-unrestricted use of pediatric treatment regimens.
Response to the ALL-96 protocol was identical for both age groups.
Increased hematologic toxicity was noted in young adults compared to adolescents.
Findings support the use of pediatric regimens in treating older patients with SR ALL.

Abstract

The response to the pediatric ALL-96 protocol was identical in adolescents and young adults despite a slight increase in hematologic toxicity observed in adults. This justifies the age-unrestricted use of pediatric regimens to treat patients with SR ALL.

AIに質問

Bookmark